Teresa S. Sligh MD

Internal Medicine•Burbank, CA

Physician

Join to View Full Profile

3808 W Riverside DrBurbank, CA 91505
Phone+1 818-558-7555
Fax+1 818-558-4099

Education & Training

Texas Health Resources (Dallas)Residency, Internal Medicine, 1996 - 1998
Texas A&M; Health Science Center College of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 2000 - 2026
TX State Medical License 1998 - 2025
Academy of Physicians in Clinical ResearchCertified Physician Investigator (CPI)

Clinical Trials

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin Start of enrollment: 2008 Dec 01
Terminated
Phase 2
The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza Start of enrollment: 2012 Nov 01
Completed
Phase 1, Phase 2
Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
Terminated
Phase 2
Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee Start of enrollment: 2013 Jun 01
Completed
Phase 3
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
Completed
Phase 3
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
Completed
Phase 3
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) Start of enrollment: 2016 May 19
Completed
Phase 2
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism Start of enrollment: 2017 Apr 03
Completed
Phase 1
Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure Start of enrollment: 2017 Jun 05
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

7 citations
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis.
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda D'Cunha, Teresa Sligh, Laura K Ferris
Clinical and Translational Science. 2024-01-01
2 citations
Evaluation of modern pathologic nomenclature, tumor imaging and treatment of pituitary adenomas in a recent surgical series
Alan Y.C. Cheung, Teresa Sligh, Steven Bauserman, Gregory Schultz
Journal of Neuro-Oncology. 1998-04-01
5 citations
Austin bunionectomy using single screw fixation: five-year versus 18-month follow-up findings.
W. Preston Goforth, Joe E. Martin, Daniel S. Domrose, Teresa S. Sligh
The Journal of Foot and Ankle Surgery. 1996-05-01

Press Mentions

‘Integrated Site Organization’ Expands Further in NY and CAL to Become Force for Clinical ResearchJuly 14th, 2021

Teresa S. Sligh MD

Dr. Sligh is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.